Liso-cel now has five approved indications, the most of any CD19-targeted CAR T-cell therapy.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-okays-car-t-cell-therapy-marginal-zone-lymphoma-2025a1000y5g?src=rss
Author :
Publish date : 2025-12-05 16:22:00
Copyright for syndicated content belongs to the linked Source.
